Outlook Therapeutics (OTLK) Total Debt (QoQ) (2016 - 2025)
Outlook Therapeutics (OTLK) Total Debt (QoQ) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Jun 30, 2025 |
-2.89% |
| Dec 31, 2021 |
-11.77% |
| Mar 31, 2021 |
-98.79% |
| Dec 31, 2020 |
1,078.71% |
| Sep 30, 2020 |
65.93% |
| Jun 30, 2020 |
2,019.58% |
| Mar 31, 2020 |
-32.36% |
| Dec 31, 2019 |
-99.44% |
| Sep 30, 2019 |
-0.19% |
| Jun 30, 2019 |
-12.10% |
| Mar 31, 2019 |
5,261.07% |
| Dec 31, 2018 |
-13.02% |
| Sep 30, 2018 |
-16.80% |
| Jun 30, 2018 |
-14.05% |
| Mar 31, 2018 |
-98.13% |
| Dec 31, 2017 |
-7.14% |
| Sep 30, 2017 |
6,057.01% |
| Jun 30, 2017 |
-96.82% |
| Mar 31, 2017 |
32.48% |
| Dec 31, 2016 |
81.72% |
